<DOC>
	<DOCNO>NCT02800317</DOCNO>
	<brief_summary>Chemotherapy clinically node positive breast cancer patient increasingly administrate neoadjuvant setting . The standard treatment regimen case : neoadjuvant chemotherapy ( NAC ) follow breast surgery axillary lymph node dissection ( ALND ) . NAC result axillary pathologic complete response ( pCR ) 1 3 patient , indicate complete absence axillary metastasis completion NAC . In event , ALND regard overtreatment creates unnecessary morbidity . Less invasive axillary surgery accurately assess axillary pCR therefore preferred standard ALND patient . In case detection remain axillary lymph node metastases less invasive axillary surgical procedure , completion axillary treatment standard care . The novel RISAS procedure introduce possible less invasive axillary staging procedure . RISAS procedure contain Radioactive Iodine Seed localisation Axilla axillary node positive breast cancer combine Sentinel node procedure . The iodine seed axillary lymph node metastasis place prior start NAC .</brief_summary>
	<brief_title>RISAS Procedure Node Positive Breast Cancer Following NAC</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female patient pathologically confirm axillary lymph node positive invasive primary breast cancer , treat neoadjuvant chemotherapy Willing able undergo study procedure . Has personally provide write informed consent . Age &lt; 18 Pregnancy lactation Contra indication undergo iodine seed placement sentinel lymph node biopsy , allergic reaction iodine , 99m Technetium patent blue . Recurrent breast cancer Previous axillary surgery radiotherapy Patients periclavicular lymph node metastasis ( cN3 ) Patients advanced breast cancer ( i.e . patient distant metastasis , treat without furter surgical procedure )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>